Evaxion A/S American Depositary ShareEVAX

Evaxion is a pioneering TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases. With AI-Immunology we conduct rapid, efficient and high-quality target discovery, drug design and.

evaxion.ai